NDC11 00002898001
This exact 11-digit normalized identifier can correspond to more than one FDA hyphenation. FDA.report preserves the exact identifier and exposes every structurally valid candidate without guessing.
Possible FDA NDC forms#
| Package NDC | Product root |
|---|---|
| 00002-8980-01 | 00002-8980 |
| 00002-8980-1 | 00002-8980 |
| 0002-8980-01 | 0002-8980 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Rezvoglar KwikPen | INSULIN GLARGINE-AGLR | Eli Lilly and Company | f6af8706-2058-4fe1-99c8-43684c20bfa2 | 2024-08-09 | Warnings, Adverse reactions | 0002-8980-01 0002-8980 00002898001 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.